newswire
.in
← All releases
general
globenewswire_business
6/25/2026
0 views
Eliaz Therapeutics Highlights Selective Galectin-3 Removal in Sepsis, Advances XGAL-3® Program
Eliaz Therapeutics Highlights Selective Galectin-3 Removal in Sepsis, Advances XGAL-3® Program
View original →